ARKG Investment Tracker

Source from:official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 111,888 shares, the number of shares held decreased 4.08% compared to the previous period and now represents 3.79% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in Veracyte by 50,616 shares, the number of shares held decreased 4.08% compared to the previous period and now represents 4.61% of the total position.
      7Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 1,036 shares, the number of shares held decreased 4.1% compared to the previous period and now represents 0.98% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in Veeva by 2,701 shares, the number of shares held decreased 4.11% compared to the previous period and now represents 1.3% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 89,170 shares, the number of shares held decreased 4.08% compared to the previous period and now represents 9.53% of the total position.
      68Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 477,115 shares, the number of shares held decreased 4.08% compared to the previous period and now represents 7% of the total position.
      16Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in Tempus AI by 27,572 shares, the number of shares held decreased 2.06% compared to the previous period and now represents 4.41% of the total position.
      55Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 90,021 shares, the number of shares held decreased 4.08% compared to the previous period and now represents 3.84% of the total position.
      2Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 509,231 shares, the number of shares held decreased 4.08% compared to the previous period and now represents 1.88% of the total position.
      15Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 121,064 shares, the number of shares held decreased 4.08% compared to the previous period and now represents 2.58% of the total position.
      2Comment
      Report
     
     
     
     

    Most Discussed

     
     
     
     
     

    Company: TTMF Limited. Tech supported by Xiangshang Yixin.

    Email:uservice@ttm.financial